AstraZeneca PLC vs Pfizer Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- AstraZeneca PLC is the larger company by market value: $242.6 B against $170.7 B for Pfizer Inc., 1.4 times as much (market caps of Aug 1, 2026 for AstraZeneca PLC and Oct 30, 2026 for Pfizer Inc.). AstraZeneca PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Pfizer Inc. had more revenue: $62.6 B against $58.7 B for AstraZeneca PLC, both in the year to December 2025.
- AstraZeneca PLC earned more: net income of $10.2 B against $7.8 B for Pfizer Inc.
- AstraZeneca PLC keeps more of each dollar of sales: a net margin of 17.4% against 12.4% for Pfizer Inc.
- AstraZeneca PLC employs more people: 89,900 against 75,000 at Pfizer Inc. Each employee brings in about $653,382 of revenue at AstraZeneca PLC and $834,387 at Pfizer Inc.
- On price to earnings, Pfizer Inc. trades at 42.3× and AstraZeneca PLC at 23.7×: investors pay more for each dollar of Pfizer Inc.'s profit.
- AstraZeneca PLC's revenue grew faster in its latest fiscal year: +8.6% against -1.6% for Pfizer Inc.
- On the Piotroski F-score, a nine-point test of improving finances, AstraZeneca PLC scores 8 and Pfizer Inc. 5.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | AstraZeneca PLC AZN · #76 in the world | Pfizer Inc. PFE · #127 in the world |
|---|---|---|
| Profile | ||
| Country | 🇬🇧 UK | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1999 | 1849 |
| Size | ||
| Market cap | $242.6 B | $170.7 B |
| Revenue | $58.7 B | $62.6 B |
| Net income | $10.2 B▲ best | $7.8 B |
| Employees | 89,900 | 75,000 |
| Valuation | ||
| P/E ratio | 23.7× | 42.3× |
| Price to sales | 4.1× | 2.7× |
| Price to book | 5.0× | 2.0× |
| Free cash flow yield | 4.8% | 5.3%▲ best |
| Profitability | ||
| Gross margin | 81.9%▲ best | 74.3% |
| Operating margin | 23.4% | — |
| Net margin | 17.4%▲ best | 12.4% |
| Return on equity | 22.9%▲ best | 8.9% |
| Return on invested capital | 17.5% | — |
| Growth | ||
| Revenue growth | 8.6%▲ best | -1.6% |
| Revenue growth, 3 years a year | 9.8%▲ best | -14.8% |
| Earnings per share growth | 45.3%▲ best | -3.5% |
| Financial strength | ||
| Debt to equity | 0.5×▲ best | 0.7× |
| Interest cover | 8.1× | — |
| Cash | ||
| Free cash flow margin | 20.0%▲ best | 14.5% |
| Shareholder returns | ||
| Dividend yield | 2.0% | — |
| Shareholder yield | 2.3% | — |
| Strength scores | ||
| Piotroski F-score | 8 of 9▲ best | 5 of 9 |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, AstraZeneca PLC or Pfizer Inc.?
AstraZeneca PLC is the larger company by market value: $242.6 B against $170.7 B for Pfizer Inc., 1.4 times as much (market caps of Aug 1, 2026 for AstraZeneca PLC and Oct 30, 2026 for Pfizer Inc.). AstraZeneca PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, AstraZeneca PLC or Pfizer Inc.?
Pfizer Inc. had more revenue: $62.6 B against $58.7 B for AstraZeneca PLC, both in the year to December 2025. AstraZeneca PLC earned more: net income of $10.2 B against $7.8 B for Pfizer Inc.
Which is more profitable, AstraZeneca PLC or Pfizer Inc.?
AstraZeneca PLC keeps more of each dollar of sales: a net margin of 17.4% against 12.4% for Pfizer Inc.
Which has more employees, AstraZeneca PLC or Pfizer Inc.?
AstraZeneca PLC employs more people: 89,900 against 75,000 at Pfizer Inc. Each employee brings in about $653,382 of revenue at AstraZeneca PLC and $834,387 at Pfizer Inc.
Is AstraZeneca PLC cheaper than Pfizer Inc.?
On price to earnings, Pfizer Inc. trades at 42.3× and AstraZeneca PLC at 23.7×: investors pay more for each dollar of Pfizer Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
Which is growing faster, AstraZeneca PLC or Pfizer Inc.?
AstraZeneca PLC's revenue grew faster in its latest fiscal year: +8.6% against -1.6% for Pfizer Inc.
Which is financially stronger, AstraZeneca PLC or Pfizer Inc.?
On the Piotroski F-score, a nine-point test of improving finances, AstraZeneca PLC scores 8 and Pfizer Inc. 5.
More about AstraZeneca PLC
More about Pfizer Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.